Shots:
- The US FDA has approved the Altaviva device, an implantable tibial neuromodulation therapy to treat urge urinary incontinence
- Altaviva device is placed under the skin above the fascia & near the ankle in a minimally invasive, sedation & imaging-free procedure to restore bladder–brain communication & improve bladder control by delivering electrical impulses to the tibial nerve
- Altaviva device offers a 15yr. battery life with automatic therapy requiring no daily input & recharges in ~30min. at default speed, plus it is MRI-compatible for planned or unexpected imaging
Ref: Medtronic | Image: Medtronic | Press Release
Related News:- Medtronic Reports the European CE Mark of MiniMed 780G System for Automated Insulin Delivery
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
